The Translational Research Grant (TRG) program funds research projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions. The technology must have the potential to solve a real-world problem as a commercial product in the life sciences sector.
The goals of the TRG program include:
Applicants must be researchers employed by a North Carolina-based university or nonprofit research institute. Technical projects may be conducted at awardee institutions or outsourced to contract research organizations.
Proposals will be evaluated on the composition of the project team, including a project manager, and the setting of relevant, realistic, and achievable milestones during the product development tasks.
All applicants should read these TRG Proposal Guidelines & Instructions thoroughly prior to preparing an application. If you have any questions about the program, use the contact information at the end of this document.
• Important First Step - The PI must register for an account on the NCBiotech Funding Portal at least five days prior to the deadline in order to submit a proposal. The funding portal link is https://ncbiotech.fluxx.io.
If you have applied for a grant using the funding portal previously (for any NCBiotech funding program), you do not need to register again.
• A maximum of $130,000 may be requested, with a $14,000 supplement available to engage the required project manager.
• Projects may last up to 24 months.
• No match is required, except for any request for a single piece of equipment costing over $25,000, in which case a 25% cash match is required.
• NCBiotech grants do not pay for any type of overhead or indirect costs.
• The review process includes evaluation of a written proposal with associated materials and a recorded pitch style presentation video, all of which must be submitted by the deadline listed above.
Success with NCBiotech funding isn’t driven solely by the scientific novelty of a project — many programs emphasize commercial relevance, economic impact, collaboration, and ecosystem development. The following predictors are consistently reflected in funded portfolios and program guidance:
1. Clear Alignment with NCBiotech’s Mission
Successful proposals align strongly with NCBiotech’s stated mission to support biotechnology innovation, commercialization, company growth, and workforce development within the state. Projects that directly contribute to economic or commercialization outcomes — in addition to scientific merit — tend to stand out. Wikipedia
Examples:
Early translational research with a clear plan for commercialization
Work that enables new biotech products or services
Initiatives tied to workforce training or industry growth
2. Demonstrated Commercial Potential or Technology Readiness
Many of NCBiotech’s programs (e.g., Flash Grants, TRGs) prioritize projects with a plausible path to market or further investment rather than purely exploratory science. Reviewers ask: Does the project advance a product, process, or innovation that stakeholders value? cas.uncg.edu
Success predictors include:
Evidence or documentation of unmet need
Metrics for technology readiness, prototyping, or validation
Identification of potential industry partners or customers
3. Strong Partnerships & Collaboration
Funds such as the Collaborative Funding Grant (CFG) explicitly require collaboration between university researchers and industry partners. Successful projects often involve multi-disciplinary teams from academia and biotech companies working together toward common goals. Kenan Institute
Why this matters:
Demonstrates real-world relevance
Shows maturity beyond basic research
Signals readiness for commercialization or scaling
4. Feasible & Well-Justified Budgets
NCBiotech expects budget requests to be directly tied to project deliverables and matched to the scale and scope of the program. For example:
Flash grants are relatively small — budgets must be tight and purposeful. cas.uncg.edu
Equipment or facility requests (Innovation Impact Grants) must show broad institutional benefit. Home
Predictor: Budgets that are realistic, clearly justified, and aligned with the planned activities.
5. Institutional and Regulatory Preparedness
Funded applicants tend to demonstrate that:
Institutional support exists (e.g., letters of support from department chairs or tech transfer offices)
Regulatory or compliance planning is addressed (e.g., human subjects, biosafety) where relevant
This reduces perceived risk and shows readiness to implement the project.
6. Potential for Follow-On Funding or Impact Scaling
Projects that build toward larger goals (e.g., future NIH/NSF funding, venture capital interest, or commercial licensing) are competitive because they extend NCBiotech’s impact. Funders view early awards as de-risking investments that unlock future capital or outcomes.
7. Broad Benefit or Ecosystem Impact
Whether it’s developing workforce pipelines, holding biotech networking events, or strengthening university cores, successful applicants articulate how the work benefits more than just the PI’s lab — e.g., multiple investigators, students, or the statewide biotech community.
✔ Frame your project in terms of commercial impact and practical outcomes.
Articulate the problem you’re solving for industry, patients, or customers, not just the science.
✔ Show credible routes to next-stage milestones.
Even if you are at an early stage, include measurable indicators of progress and plans for follow-on support.
✔ Build meaningful partnerships.
Connect with relevant biotech companies, entrepreneurs, or tech transfer offices early.
✔ Engage your institution’s research support offices.
Letters of support and institutional team alignment improve credibility.
✔ Tailor to the specific grant type.
NCBiotech funds different activities (research, equipment, events) and each has its own expectations — follow guidelines closely.
| Predictor | Why It Matters |
|---|---|
| Alignment with NCBiotech mission | Core criterion for funding relevance Wikipedia |
| Commercial potential or translation pathway | Key for innovation and impact programs cas.uncg.edu |
| Partnership with industry or multiple stakeholders | Strengthens feasibility and ecosystem relevance Kenan Institute |
| Well-justified, feasible budget | Matches scale and improves credibility cas.uncg.edu |
| Institutional support & readiness | Reduces implementation risk |
| Clear route to next funding or impact | Enhances long-term value |
Eligible Institutions
Proposals may be submitted by any North Carolina university or non-profit research organization. ⊗ Projects that appear to be subsidized R&D for any commercial entity may be administratively declined. Direct funding of R&D expenses for commercial firms, except contracted services, even if they have ties to NC-based universities and research institutions, is not consistent with the objectives of the program.
Principal Investigator Eligibility
At the time of submission, the Principal Investigator (PI) must hold a full-time, tenure-track or tenured faculty appointment, or an appointment as full-time research faculty with a dedicated independent lab at the applicant institution, or an equivalent faculty designation in a medical/professional school.
⊗ The PI may not have more than two active awards from the North Carolina Biotechnology Center at the same time.
Intellectual Property Eligibility
Eligible projects support inventions that, at a minimum, have been disclosed to the university’s technology transfer office at the time of application. The applicant must attest that the IP rights are assigned to the applicant’s institution and have not been committed through license or option to license to any third party at the time of application.
Eligible Countries:
Sponsor Institute/Organizations: North Carolina Biotechnology Center
Sponsor Type: Corporate/Non-Profit
Address: 15 T.W. Alexander Drive Durham, NC 27713-2847
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 28, 2026
Jan 28, 2026
$144,000
Affiliation: North Carolina Biotechnology Center
Address: 15 T.W. Alexander Drive Durham, NC 27713-2847
Website URL: https://www.ncbiotech.org/funding/grants/translational-research-grant
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.